Author/Authors :
bandiera, simonetta institut de recherche sur les maladies virales et hépatiques, Strasbourg, France , bandiera, simonetta université de strasbourg, Strasbourg, France , baumert, thomas f. nouvel hôpital civil, Strasbourg, France , baumert, thomas f. université de strasbourg, Strasbourg, France , baumert, thomas f. institut de recherche sur les maladies virales et hépatiques, Strasbourg, France , zeisel, mirjam b. université de strasbourg, Strasbourg, France , zeisel, mirjam b. institut de recherche sur les maladies virales et hépatiques, Strasbourg, France
Abstract :
Hepatocellular carcinoma (HCC) is a major challenge forglobal health. Indeed, HCC represents the third leading and fastest rising cause of cancer death worldwide. About 90% of HCC cases can be associated with a wellcharacterized underlying risk factor including chronic hepatitis B, hepatitis C, ethanol consumption, aflatoxin exposure, non-alcoholic fatty liver disease, metabolic diseases like diabetes, and hereditary liver disease.
